| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-07 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-07 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-07 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-07 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-07 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-07 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-06 |